Massachusetts General Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Massachusetts General Hospital brings 1 presentation to ASH 2026 in New Orleans. Its program centres on inherited hemolytic anemias caused by red cell membrane and enzyme defects, including emerging treatments. It also covers B-cell-directed therapy for immune thrombocytopenia, AML management and immune therapy for myeloma.
| Organization | ASH 2026 Attendance |
|---|---|
Massachusetts General Hospital Boston, MA | |
Harvard-affiliated teaching hospital in Boston and a founding member of the Mass General Brigham health system. | Symposium Fri Dec 11 7:00am–10:00am B-Cell–Directed Therapies in Immune Thrombocytopenia: Real-World Practice Newer B-cell-targeting treatments for immune thrombocytopenia and how to fit them into care to achieve lasting platelet responses. Symposium Fri Dec 11 7:00am–10:00am Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials. Symposium Fri Dec 11 3:00pm–6:00pm Immune Therapy for Myeloma: From CAR T and T-Cell Engagers to Community Care Sequencing CAR-T and T-cell engagers for relapsed myeloma, when to refer, managing toxicity, and options after B-cell maturation antigen therapy fails. Talk Emerging Therapies for Treatment of Hereditary Hemolytic Anemias New treatments beyond transfusion and spleen removal for inherited hemolytic anemias outside hemoglobin disorders, from pyruvate kinase activators to gene repair. Session Hemolysis Beyond Globin: Managing Inherited RBC Membrane and Enzyme Disorders Genetic diagnosis of inherited red cell membrane and enzyme disorders, and treatment with pyruvate kinase activators, stem cell transplant or gene therapy. |
Instantly find 20 buyers from Massachusetts General Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction